title: Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate.
authors.forename: Hiroto
authors.initials: H
authors.lastname: Narimatsu
authors.forename: Giichiro
authors.initials: G
authors.lastname: Oiso
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Ono
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D017277:Drug Approval; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007564:Japan; D056687:Off-Label Use; D019172:Transplantation Conditioning; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate